BRD4

From WikiMD's WELLNESSPEDIA

File:Protein BRD4 PDB 2oss.png
Protein BRD4 PDB 2oss

BRD4

BRD4 is a protein that in humans is encoded by the BRD4 gene. It is a member of the bromodomain and extraterminal domain (BET) family of proteins. BRD4 plays a crucial role in regulating gene transcription by binding to acetylated histones and facilitating the recruitment of transcriptional machinery to specific genomic loci.

Structure[edit]

BRD4 consists of two bromodomains at the N-terminus and an extraterminal domain at the C-terminus. The bromodomains are responsible for recognizing and binding to acetylated lysine residues on histone proteins, while the extraterminal domain interacts with various transcription factors and coactivators.

Function[edit]

BRD4 functions as a transcriptional regulator by promoting the expression of genes involved in cell proliferation, differentiation, and survival. It also plays a role in the regulation of the cell cycle and is implicated in various cellular processes, including chromatin remodeling and DNA repair.

Clinical Significance[edit]

Aberrant expression of BRD4 has been associated with several human diseases, including cancer, cardiovascular disorders, and neurological conditions. Targeting BRD4 with small molecule inhibitors has emerged as a promising therapeutic strategy for the treatment of cancer and other diseases.

Interactions[edit]

BRD4 interacts with a variety of proteins involved in transcriptional regulation, chromatin remodeling, and signal transduction pathways. Some of its known binding partners include p53, MYC, and NF-κB.

Role in Cancer[edit]

Dysregulation of BRD4 has been implicated in the development and progression of various types of cancer, including leukemia, lymphoma, and solid tumors. Inhibition of BRD4 has shown promising results in preclinical studies and clinical trials as a potential treatment for cancer.

References[edit]

This article is a stub related to food. You can help WikiMD by expanding it!




Sponsored Health Resource

W8MD weight loss success

W8MD Weight Loss, Sleep & MedSpa

Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.

GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.

Book a W8MD appointment · View GLP-1 specials

Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.

Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.

Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.